APIM-peptide Targeting PCNA Improves the Efficacy of Docetaxel Treatment in the TRAMP Mouse Model of Prostate Cancer

Oncotarget - United States
doi 10.18632/oncotarget.24357
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors
Publisher

Impact Journals, LLC

Related search

Prevention of Prostate Cancer With Oleanane Synthetic Triterpenoid CDDO-Me in the TRAMP Mouse Model of Prostate Cancer

Cancers
Cancer ResearchOncology
2011English

Lobe-Specific Carcinogenesis in the Transgenic Adenocarcinoma of Mouse Prostate (TRAMP) Mouse Model

2013English

Orthotopic Treatment Model of Prostate Cancer and Metastasis in the Immunocompetent Mouse: Efficacy of Flt3 Ligand Immunotherapy

International Journal of Cancer
Cancer ResearchOncology
2003English

Glipizide Suppresses Prostate Cancer Progression in the TRAMP Model by Inhibiting Angiogenesis

Scientific Reports
Multidisciplinary
2016English

Continuous Docetaxel Chemotherapy Improves Therapeutic Efficacy in Murine Models of Ovarian Cancer

Molecular Cancer Therapeutics
Cancer ResearchOncology
2010English

Targeting the PI3K/AKT Pathway for the Treatment of Prostate Cancer

Clinical Cancer Research
Cancer ResearchOncology
2009English

Pharmacogenomic Biomarkers in Docetaxel Treatment of Prostate Cancer: From Discovery to Implementation

Genes
Genetics
2019English

BHBA Treatment Improves Cognitive Function by Targeting Pleiotropic Mechanisms in Transgenic Mouse Model of Alzheimer's Disease

FASEB Journal
BiochemistryBiotechnologyGeneticsMolecular BiologyMedicine
2019English

Docetaxel and Doxorubicin Codelivery by Nanocarriers for Synergistic Treatment of Prostate Cancer

Frontiers in Pharmacology
Pharmacology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy